Pediatric PET/MR Image Registry
Key facts
- Where
- Palo Alto, United StatesSee the site
Where in United States
- Stanford University, School of MedicinePalo Alto, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Stanford University
- Trial code
- NCT03458520
- Record updated
- 9 February 2026
- Original description
The purpose of this study is to compare whole body magnetic resonance (MR) imaging, whole body positron emission tomography (PET)/MR imaging, and (if available) PET/Computed Tomography (CT) imaging for the diagnosis of tumors in children and young adults. Sensitivities, specificities and diagnostic accuracies of the different imaging modalities will be compared for significant differences.Read full original descriptionShow less
The purpose of this study is to compare whole body magnetic resonance (MR) imaging, whole body positron emission tomography (PET)/MR imaging, and (if available) PET/Computed Tomography (CT) imaging for the diagnosis of tumors in children and young adults. Sensitivities, specificities and diagnostic accuracies of the different imaging modalities will be compared for significant differences.
Inclusion: Patients with proven solid tumors or newly diagnosed mass strongly suspected to represent a solid tumor; We might also include some patients with leukemia if there is concern for a focal lesion in any of their organs; Participant's parents (if participant is under 18) or the participant (if participant is 18 years or older) must willingly give written informed consent prior to any image transfer to the image registry.
Exclusion: Patient has contraindications for MRI or PET/MR. This includes patients with cardiac pacemakers or intracranial vascular clips as well as patients with a blood glucose level > 200 mg/dl; Lack of parental permission (if participant is younger than 18) or lack of informed consent (if participant is at least 18 years of age); Patient has a CNS primary tumor; Pregnant women and fetuses.